SLC49A4 and cancer: We identified the top 20 pathways significantly enriched in the RCC4-P compared to the RCC4-KO-643 IP (Figure 3a) and found that among the highest-ranking pathways identified were “Metabolic Reprogramming in Cancer” and “Glycolysis Activation in Cancer (Warburg Effect)”.